ICH To Address Postmarketing Issues As Possible Topic At May Meeting
Executive Summary
Postmarketing issues surrounding drug products will be taken up as a new topic for consideration at the May meeting of the International Conference on Harmonization Steering Committee in Tokyo.
You may also be interested in...
Product Safety Update Report Burden Of Analysis Is On Sponsors, FDA Says
Sponsors would bear responsibility for analyzing safety data under FDA's plans to implement product safety update report requirements established by the International Conference on Harmonization.
Product Safety Update Report Burden Of Analysis Is On Sponsors, FDA Says
Sponsors would bear responsibility for analyzing safety data under FDA's plans to implement product safety update report requirements established by the International Conference on Harmonization.
ICH Implementation May Sap Resources From Product Review, CBER Says
Implementation of the International Conference on Harmonization's Common Technical Document could temporarily drain resources from product review, Center for Biologics Evaluation & Research Associate Director for Review Management Robert Yetter, PhD, warned.